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Summary Immunological markers improve specificity and accuracy of cell detection, therefore it is important
to evaluate their usefulness in improving standard histological procedures.
This study investigates whether immunocytochemical techniques increase the accuracy ofdetection, in axillary
lymph nodes, of metastatic cells from infiltrating breast lobular carcinoma (ILC).
Fifty cases of ILC reported to be node-negative were selected. New serial sections were cut from a total of
767 lymph nodes, stained with H&E and tested in immunoperoxidase (ABC procedure) with a conventional
anti-Epithelial Membrane Antigen (EMA) serum, with a monoclonal raised against human milk fat globule
membranes (HMFG-2) and with a monoclonal against 54kd keratin. Metastases were detected immuno-
cytochemically in 12 cases (24%); in five of these cases metastatic cells were also visible in serial H&E
sections. Monoclonals offered no evident advantage over anti-EMA conventional antiserum. Immunocyto-
chemical positivity alone is not sufficient evidence for metastatic invasion since macrophages occasionally
appear EMA- and HMFG-2-positive (probably because of secondary incorporation of the antigen), and so an
improvement in the accuracy of breast cancer metastatic cell detection in axillary lymph nodes requires a
combined histo-immunological approach.
Prognosis and treatment of breast cancer is heavily
influenced by the detection of metastases in lymph
nodes. Foci formed by clumps of cells are easily
spotted in standard histological sections, but a
more difficult task is the detection of metastatic
foci of one or few cells spread within a tissue.
In as many as 24% of lymph nodes reported free
of metastases by standard histological examination,
various authors found metastases when multiple or
serial sections were cut (Pickren, 1961; Fisher et al.,
1978b). Immunological markers also improve the
specificity and accuracy of cell detection, therefore
it is important to evaluate their usefulness in
improving standard histological procedures.
Wells et al. (1984) utilizing 3 monoclonal
antibodies found micro-metastatic foci in about
20% of lymph nodes from 45 cases of ductal or
lobular breast cancer reported negative on
conventional histology. On the contrary Sloane et
al. (1980) reached the conclusion that detection of
metastases in lymph nodes was not improved by
immunocytochemistry. However they used a
polyclonal antiserum against fat globule membranes
of human milk.
In this study 50 cases of infiltrating lobular
carcinoma of the breast reported to have axillary
lymph nodes free of metastases were re-examined to
determine whether occult metastases were revealed
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by a higher number of sections and by immuno-
cytochemical procedures and, in cases where
metastatic cells could be detected immunocyto-
chemically, whether a substantial difference in
results using monoclonal antibodies and polyclonal
antisera was demonstrable.
Cases of infiltrating lobular carcinoma rather
than the more common ductal carcinoma were
examined, because metastatic spread from the
former is difficult to diagnose since neoplastic cells
are often 'benign-looking' (Ashton et al., 1975) and
tend to fill the sinuses, mimicking sinus
histiocytosis (Rosai, 1981), or to invade the
lympho-reticular tissue in a lymphoma-like pattern
difficult to detect on standard histological sections
(McDivitt et al., 1968).
Materials and methods
The specimens consisted of axillary lymph nodes
which had been removed at surgery for infiltrating
lobular breast carcinoma (ILC). Fifty cases
reported to be free of metastases after routine
examination of axillary lymph nodes (a minimum of
10 lymph nodes and 15 on the average having been
examined), observed between 1978 and 1983 were
selected from the files of our two Institutions and
of the S. Anna Gynecological Hospital of Turin
according to the following criteria: (a) the follow up
was available for a minimum of 2 years, (b) no type
of therapy had been administered after the first
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operation, (c) the original histological sections
(stained with H&E) and the paraffin blocks were
available.
The blocks were re-cut and 5 serial sections were
obtained on gelatinized slides. The first of the
sections was stained with H&E. The other 4
sections were employed for the immunocyto-
chemical technique. The ABC procedure (Hsu et
al., 1981) was used, with a minor modification to
avoid non specific staining of mast cells (Bussolati
& Gugliotta, 1983). Endogenous peroxidase was
abolished by the hydrogen peroxide-periodic acid-
borohydride sequence (Heyderman & Neville,
1977).
The following markers were employed:
1. Goat anti-Epithelial Membrane Antigen (EMA)
from Sera Lab, U.K. (diluted 1:400).
2. Mouse monoclonal antibody against human
milk fat globule membrane (HMFG-2) (diluted
1: 10), a kind gift from Dr J. Taylor
Papadimitriou - Imperial Cancer Research
Fund, London. Of the two monoclonals
produced in Dr Taylor Papadimitriou's
Laboratory, HMFG-2 and not HMFG-1 was
used, because the epitope recognized by the
former is more frequently expressed in
metastatic breast cancer cells (Burchell et al.,
1983).
3. Mouse monoclonal antibody against 54kd
human keratin (diluted 1:500) described by
Gown & Vogel (1984) and supplied by ENZO
Biochem (USA). The type of keratin recognized
by this antibody is commonly expressed in all
epithelial cells (but not lymphoid cells). In
preliminary experiments we found that this
monoclonal, although giving better results on
alcohol fixed tissues as is the case for all anti-
keratin antibodies (Altmannsberger et al., 1981),
gives a weak but specific staining of breast
cancer metastatic cells also in formalin-fixed
tissues.
One of the sections was used as a control, treated
with normal mouse serum (diluted 1:50) and then
processed with horse anti-mouse biotinylated
antibody and the ABC procedure.
In special cases, to identify immuno-
cytochemically positive cells, photographs of the
corresponding area of serial H&E stained slides
were taken. The slide was then unmounted and
processed first with standard treatment to abolish
the endogenous peroxidase (which removes both
haematoxylin and eosin stains) and then for
immunocytochemistry. The morphology of the cells
could then be easily recognized and pictures of the
same cells, before and after immunocytochemistry,
compared.
To identify macrophages, rabbit antisera against
chymotrypsin and alpha-I anti-trypsin were
employed (both diluted 1:100; from Dako,
Denmark). These enzymes are regarded as
macrophage markers (Motoi et al., 1980; Isaacson
et al., 1981).
Results
Metastatic ILC cells gave a strong reaction with a
similar distribution with both the anti-EMA serum
and HMFG-2 antibody, in one case however a
group of metastatic cells was positive only with the
former. The staining was mainly localized over the
cell surface and in occasional intra-cytoplasmic
vacuoles with the typical 'targetoid' pattern (Eusebi
et al., 1977). A faint diffuse cytoplasmic staining
was also a rather common finding.
The anti-keratin antibody gave a negative
reaction in lymphoid cells and a definite, although
rather weak, staining of ILC metastatic cells. It was
thus better not to rely on the use of this
monoclonal for recognizing metastatic cells at low-
magnification scanning: this was instead feasible on
sections stained with the anti-EMA serum. The two
monoclonals on serial sections were a useful control
of the results obtained with the anti-EMA serum.
In one case anti-EMA serum markedly stained
small cytoplasmic dots in a large number of cells
located mostly in the peripheral sinuses. This
finding was present in an appreciable number of
cells in another 5 cases. These cells were interpreted
as macrophages because of the positive staining on
serial sections with chymotrypsin and alpha-I
antitrypsin and the oval, clear nucleus with ample,
star-like cytoplasm (Figure la-c). These cells were
totally unreactive with anti-keratin serum.
Occult metastases were detected by the antisera
in 12 of the 50 cases examined with a total of 26
positive lymph nodes out of the 767 lymph nodes
examined.
Metastatic cells occurred mostly as isolated, non-
cohesive cells either in the sinuses or in the diffuse
lymphoid tissue. In the sinuses they appeared
between histiocytes and occasionally filled the
sinuses in a rather compact fashion (Figure 2). In
some cases, no or very few epithelial metastatic
cells were observed in the sinuses, while positive
cells were scattered in a diffuse pattern between
lymphoid cells in the cortex and medulla (Figure
3a, b; 4a, b).
Examination of the H&E sections serial to the
immunocytochemically stained ones identified
cancer cells in 7 nodes (5 cases) out of the 26
positive lymph nodes. An independent observer
reached the same conclusion. In one of the 5DETECTION OF METASTASES FROM BREAST CARCINOMA 633
Figure 1 Axillary lymph node from a case of ILC. In the peripheral sinus several cells display cytoplasmic
positivity for EMA (a). On serial sections the cells are interpretable as macrophages, both morphologically on
H&E slides (b) and because of reactivity with anti-chymotrypsin antiserum (c). ( x400)
Figure 2 Axillary lymph node from a case of ILC.
Neoplastic EMA-positive cells engulfing the sinuses are
detectable at low magnification. On a serial H&E
slide, cancer cells could be recognized only where
present in clumps; the sparse EMA-positive cells (dark
spots on the right and lower areas) were not
morphologically identifiable (x 100).
histologically positive cases, cancer cells were found
to be present already in the original slides.
In the other 7 cases, the isolated distribution of
the metastatic cells described above seems the main
reason for failure to detect them by morphology.
This was clearly shown when H&E and peroxidase
stained photomicrographs of the same cells were
compared (Figure 4a, b). Furthermore, cells of
infiltrating lobular carcinoma often show a
vesicular inconspicuous nucleus and ample
cytoplasm which makes them resemble reactive
histiocytic cells.
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Figure 3 Axillary lymph node from a case of ILC
diagnosed on H&E slides as free from metastases (a).
A serial section stained for EMA (b) shows diffuse
infiltration by cancer cells in the cortex and medulla.
(x 100).
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Figure 4 A cortical area of an axillary lymph node
from a case of ILC, appearing free of metastatic
spread on the H&E section (a). The same section was
unmounted and re-stained for EMA (b). A
comparison of the two pictures gives evidence of the
benign-looking appearance of the cancer cells
infiltrating the lymphoid tissue. ( x 250).
The follow up of all 50 cases for a minimum of 2
and a maximum of 7 years (mean 3.5 years)
showed that 2 of the 12 (17%) immunocyto-
chemically positive cases, and 7 (2 of whom died)
of the 38 (18%) negative cases, had recurrences.
Discussion
This study focuses on the use of immunocyto-
chemistry to detect metastatic breast cancer cells
from infiltrating lobular carcinoma (ILC). In a
preliminary study in 10 cases of infiltrating ductal
carcinoma originally classified as node negative we
could not find any advantage in the use of
immunocytochemistry (unpublished observation).
Small metastatic foci were detected in 2 cases, but
these could be already recognized in serial H&E
sections. Sloane & coworkers (1980) using a
conventional anti-EMA serum were not able to
disclose an advantage of immunocytochemistry
over morphology in studying 26 cases of node
negative breast cancer patients. Wells et al. (1984)
stated that in most (but not in all) cases
examination of conventionally stained slides
adjacent to the immunocytochemically stained ones
could reveal to an informed eye the presence of
metastatic cells.
The results of this study revealed occult
metastatic foci in 24% of the cases of ILC with
lymph nodes originally classified as negative. Of
these only 10% were also revealed by serial
sectioning. These figures lead us to conclude that in
contrast with the results of our above mentioned
preliminary study and with those of Sloane et al.
(1980), immunocytochemistry has definite advantages
over routine histological examination. An explana-
tion of these contrasting conclusions possibly lies
in the fact that, contrary to the more common
ductal carcinoma, ILC cells metastasize to lymph
nodes and elsewhere (Ashton et al., 1975) in a
scattered fashion making their recognition difficult,
even more so because of their lack of severe cyto-
logical atypia. Considering that ILC cases only
account for about 10% of breast cancer histological
types and that Sloane's cases were not selected
specifically from among ILC series, it seems likely
that he observed a majority of cases where
metastases could already be detected relatively
easily at the original examination and thus
immunocytochemistry had little to add. The results
of Wells et al. (1984) were also different from those
of Sloane et al. (1984), but the explanation they
gave as most likely was that Sloane used
polyclonals whereas Wells et al., used monoclonals.
We do not agree with this explanation, because in
our experience anti-EMA antibodies were seen to
be very useful (see below). Wells et al., found that
immunocytochemistry revealed occult lymph node
metastases in 9% of 33 cases of ductal carcinomas
and in 33% of 12 cases of lobular carcinomas. This
supports our hypothesis that metastatic foci of ILC
cases have a higher risk of passing undetected when
only morphology is adopted.
A major interpretative problem is presented by
the EMA-reactive material, occasionally present
(12% of the cases) in macrophages. This material is
probably produced by the primary tumour and
secondarily incorporated by macrophages. For
diagnostic purposes the finding suggests that
immunocytochemistry should be accompanied by
histological examination.
Anti-EMA and HMFG2 antibodies showed high
specificity for neoplastic mammary epithelium
within lymph nodes, with neither having any
advantage over the other. The faint staining of
plasma cells is a pitfall that can be overcome with
nuclear counterstaining (Sloane et al., 1983;
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Heyderman et al., 1984). Staining with the anti-
keratin antibody was the least evident, probably
because the original formalin fixation was detrimental
to keratin immunostaining Altmannsberger et al.,
1981). Anti-EMA serum is known to stain occa-
sional lymphoid cells (Delsol et al., 1984). For
unknown reasons such staining is mainly observed
in lymphomas, but in our and in other workers'
experience (Sloane et al., 1983) this does not
usually happen in reactive lymph nodes. Plasma
cells did occasionally show a faint staining of the
cell membrane with anti-EMA serum; their nature
however could be easily interpreted.
The newly discovered positivity in the lymph
nodes of 12 cases was evidently determined by very
small foci of metastatic cells that can be defined as
micrometastatic because if they had been large foci
they would probably have been detected in the
original morphological examination. Fisher et al.
(1978a) in agreement with Huvos et al. (1971) and
with Attiyeh et al. (1977) observed that in breast
cancer patients in whom micrometastases measured
less than 1.3mm, the survival and treatment rates
were similar to those of node-negative patients.
Rosen & coworkers (1981) observed, however, that
patients with micrometastatic spread in axillary
lymph nodes behaved, after a long follow up
(twelve years), as high risk patients.
The follow up period and the number of cases
studied in our series are both too small for us to
reach conclusions on whether immunocyto-
chemically positive lymph node cases previously
diagnosed at morphology as negative (therefore
probably micrometastatic) carry a worse prognosis
than cases that remain negative all along. However
in this case series (with its already mentioned
limitations) we did not find that the 24% of lymph
node positive cases had an increased frequency of
recurrences or a shortened survival time.
Having now determined the technical utility of
immunocytochemistry we intend studying a large
series with long term follow up to determine
whether it also improves prognostic accuracy.
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